We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Translational Research in Clinical Proteomics
Blog

In this article, Gary Kruppa, VP of Proteomics at Bruker Daltonics, explores how proteomic methods can help achieve the ultimate goal of preventing and improving the treatment of disease.

Read More

Illuminating Cancer Cells To Help Guide Surgery
Blog

Surgery, when used as a cancer treatment, is a procedure in which a surgeon identifies and removes the cancerous tissue from a patient’s body. We recently spoke with Christopher Barys, CEO at On Target Laboratories to learn more about the novel cancer imaging agents they are currently developing, designed to help surgeons identify and resect cancerous lesions.

Read More

Applying Precision Genomics in Biopharma Drug Development
Blog

A recent collaboration between Onconova Therapeutics and Mission will utilize the Mission Bio TapestriⓇ Platform to conduct targeted single-cell DNA analysis for the study of Onconova's novel cancer therapy, Rigosertib. We spoke with Darrin Crisitello, CCO of Mission Bio, to learn more.

Read More

Empowering Cancer Patients After Diagnosis
Blog

We recently spoke with Jed Coleman, co-founder of Curve.life, an online service aiming to provide cancer patients with evidence-based information about how they can empower themselves after diagnosis.

Read More

Exploring the Fourth Dimension of Proteome Analysis
Blog

Recent developments in MS technology have enabled a fourth dimension of analysis: ion mobility separation. The term "4D proteomics" has been created to describe analysis that incorporates all four dimensions. We interviewed two researchers at the forefront of the proteomics field to learn more about how 4D proteomics approaches are enhancing their research.


Read More

10 Things to Note About Manufacturing Viral Vectors
Blog

10 things to note about viral vector manufacturing, regarding the complexities and challenges, and the technology that will help drive cell and gene therapy forward. Here we share insights from Pall and Molmed representatives, who are leaders in the fields of bioprocessing and cell and gene therapy.

Read More

Harnessing the Power of Proteins To Unlock Cell and Gene Therapies
Blog

We recently spoke with Paul Wotton, Ph.D., CEO at Obsidian Therapeutics, to gain his insights on the genetically engineered cell-therapy research area, and to learn how Obsidian Therapeutics' cytoDRiVE platform can increases the specificity and safety of such therapies.

Read More

Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata
Blog

We recently spoke with Luca Quagliata, Ph.D., Global Director of Medical Affairs for Thermo Fisher Scientific. Previously, Quagliata was involved in one of the first teams in Europe to introduce Next Generation Sequencing (NGS) in routine molecular diagnostics. Here, he shares his perspectives on the field, particularly the use of NGS in the analysis of liquid biopsies, the discovery of cancer biomarkers and the potential application of artificial intelligence (AI) in molecular diagnostics.

Read More

Single Cell Analysis – Advantages, Challenges, and Applications
Blog

We recently spoke with Dr Marian Rehak, VP of Research and Development at Sphere Fluidics, to learn more about the importance of single cell analysis. Marian touches on some of the common challenges encountered and highlights some of the key applications.

Read More

Agilent’s Latest Acquisition in the Cell Analysis Space: BioTek Instruments
Blog

Agilent Technologies Inc. recently announced it had signed an agreement to acquire BioTek Instruments, a global leader in life science instrumentation.

Read More